Journal of Pharmaceutical Sciences · 2017 · 38 citations · 38 references
Natural SciencesChemistryPharmacologyCrystal StructureSolid-state ChemistrySupramolecular ChemistryCrystal ChemistryCrystallization AnalysisCrystallization ProcessesDrug SolubilitySolid-state CharacterizationSupramolecular MaterialsCo-crystal CharacterizationCo-crystal FormationCrystal FormDrug Crystal FormDrug Polymorphism AnalysisSupramolecular InteractionsThermodynamic ConstraintsThermodynamic Profiling
Polymorphism in active pharmaceutical ingredients can be regarded as critical for the potential that crystal form can have on the quality, efficacy, and safety of the final drug product. The current contribution aims to characterize thermodynamic interrelationship of a dimorphic co-crystal, FI and FII, involving carbamazepine (CBZ) and saccharin (SAC) molecules. Supramolecular synthesis of CBZ-SAC FI and FII has been performed using thermokinetic methods and systematically characterized by differential scanning calorimetry, powder X-ray diffraction, solubility, and slurry measurements. According to the heat of fusion rule by Burger and Ramberger, FI (ΔH fus = 121.1 J/g; melting point, 172.5°C) and FII (ΔH fus = 110.3 J/g; melting point, 164.7°C) are monotropically related. The solubility and van't Hoff plot results suggest FI stable and FII metastable forms. This study reveals that CBZ-SAC co-crystal phases, FI or FII, could be stable to heat-induced stresses; however, FII converts to FI during solution-mediated transformation.
38
Polymorphs, Salts, and Cocrystals: What’s in a Name?
Srinivasulu Aitipamula, Rahul Banerjee, Arvind K. Bansal et al. · Crystal Growth & Design · 2012 · 1K citations
Pharmaceutical cocrystals: along the path to improved medicines
Naga Kiran Duggirala, Miranda L. Perry, Örn Almarsson et al. · Chemical Communications · 2015 · 917 citations
Solubility Advantage of Pharmaceutical Cocrystals
David Good, Naír Rodríguez‐Hornedo · Crystal Growth & Design · 2009 · 832 citations